Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Investigating the treatment landscape for Wilson's Disease and the potential of Monopar Therapeutics' tetrathiomolybdate (ALXN-1840).

Ticker(s): MNPR

Who's the expert?

Institution: Heidelberg University Hospital

Senior Physician (Consultant), Department of Gastroenterology and Hepatology
Manages patients with rare liver diseases, particularly Wilson disease and other metabolic liver disorders, as well as chronic liver disease and cirrhosis
Research interests include Wilson disease pathophysiology and treatment, copper metabolism, rare inherited metabolic liver diseases, and development of novel therapeutic strategies for hepatic disorders

Interview Goal

This call will cover the current treatment options available for Wilson's disease, a rare genetic disorder causing copper accumulation in the liver, brain, and eyes. The call will also cover the publicly available data on tetrathiomolybdate (ALXN-1840) from Monopar Therapeutics.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.